Filed: 5/15/2026ACC: 0001072613-26-000458
📋 What this filing means
NEA MANAGEMENT COMPANY, LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $1.76B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$1.76B
Total AUM (reported)
114.87M
Total Shares
Allocation by class
COM$1.14B64.9%
COMMON STOCK$349.66M19.9%
COM SHS$191.53M10.9%
NAMEN AKT$50.36M2.9%
COM NEW$15.03M0.9%
ADS$8.03M0.5%
COM CL A$1.98M0.1%
Portfolio Concentration
Top 3$802.07M45.6%
4–10$738.16M42.0%
11–25$218.68M12.4%
Rest$250.0K0.0%
Top 3 weight
45.6%
Top 10 weight
87.6%
Voting Authority Distribution
Total shares with voting rights: 114.87M
Sole
Full voting authority
114.87M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other26
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
Arcellx, Inc.
DFNDShares3.05M
TypeSH
Market value$349.66M
19.88%
Sole
3.05M
Shared
0.00
None
0.00
Celcuity Inc.
DFNDShares2.29M
TypeSH
Market value$260.87M
14.83%
Sole
2.29M
Shared
0.00
None
0.00
Spyglass Pharma, Inc.
DFNDShares7.39M
TypeSH
Market value$191.53M
10.89%
Sole
7.39M
Shared
0.00
None
0.00
Trevi Therapeutics, Inc.
DFNDShares13.22M
TypeSH
Market value$157.74M
8.97%
Sole
13.22M
Shared
0.00
None
0.00
Savara, Inc.
DFNDShares24.47M
TypeSH
Market value$133.61M
7.60%
Sole
24.47M
Shared
0.00
None
0.00
Monte Rosa Therapeutics, Inc.
DFNDShares7.69M
TypeSH
Market value$126.54M
7.19%
Sole
7.69M
Shared
0.00
None
0.00
MBX Biosciences, Inc.
DFNDShares3.61M
TypeSH
Market value$107.89M
6.13%
Sole
3.61M
Shared
0.00
None
0.00
Zenas BioPharma, Inc.
DFNDShares4.02M
TypeSH
Market value$78.65M
4.47%
Sole
4.02M
Shared
0.00
None
0.00
Coursera, Inc.
DFNDShares12.87M
TypeSH
Market value$74.89M
4.26%
Sole
12.87M
Shared
0.00
None
0.00
Aurinia Pharmaceuticals, Inc.
DFNDShares3.97M
TypeSH
Market value$58.83M
3.34%
Sole
3.97M
Shared
0.00
None
0.00
ORIC Pharmaceuticals, Inc.
DFNDShares4.12M
TypeSH
Market value$52.18M
2.97%
Sole
4.12M
Shared
0.00
None
0.00
CRISPR Therapeutics AG
DFNDShares1.06M
TypeSH
Market value$50.36M
2.86%
Sole
1.06M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
DFNDShares1.96M
TypeSH
Market value$21.78M
1.24%
Sole
1.96M
Shared
0.00
None
0.00
CVRx, Inc.
DFNDShares2.03M
TypeSH
Market value$19.17M
1.09%
Sole
2.03M
Shared
0.00
None
0.00
Korro Bio, Inc.
DFNDShares1.30M
TypeSH
Market value$14.69M
0.84%
Sole
1.30M
Shared
0.00
None
0.00
X4 Pharmaceuticals, Inc.
DFNDShares3.23M
TypeSH
Market value$13.36M
0.76%
Sole
3.23M
Shared
0.00
None
0.00
Champions Oncology, Inc.
DFNDShares1.71M
TypeSH
Market value$9.85M
0.56%
Sole
1.71M
Shared
0.00
None
0.00
Black Diamond Therapeutics, Inc.
DFNDShares4.45M
TypeSH
Market value$9.48M
0.54%
Sole
4.45M
Shared
0.00
None
0.00
Inventiva SA
DFNDShares1.46M
TypeSH
Market value$8.03M
0.46%
Sole
1.46M
Shared
0.00
None
0.00
Nkarta, Inc.
DFNDShares3.57M
TypeSH
Market value$7.53M
0.43%
Sole
3.57M
Shared
0.00
None
0.00
LeonaBio, Inc.
DFNDShares464.40K
TypeSH
Market value$4.77M
0.27%
Sole
464.40K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
DFNDShares3.78M
TypeSH
Market value$3.07M
0.17%
Sole
3.78M
Shared
0.00
None
0.00
Marker Therapeutics, Inc.
DFNDShares1.63M
TypeSH
Market value$2.11M
0.12%
Sole
1.63M
Shared
0.00
None
0.00
OnKure Therapeutics, Inc.
DFNDShares478.55K
TypeSH
Market value$1.98M
0.11%
Sole
478.55K
Shared
0.00
None
0.00
Gossamer Bio, Inc.
DFNDShares1M
TypeSH
Market value$328.5K
0.02%
Sole
1M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Arcellx, Inc.DFND | COMMON STOCK | 3.05M | SH | $349.66M 19.88% | 3.05M | 0.00 | 0.00 |
Celcuity Inc.DFND | COM | 2.29M | SH | $260.87M 14.83% | 2.29M | 0.00 | 0.00 |
Spyglass Pharma, Inc.DFND | COM SHS | 7.39M | SH | $191.53M 10.89% | 7.39M | 0.00 | 0.00 |
Trevi Therapeutics, Inc.DFND | COM | 13.22M | SH | $157.74M 8.97% | 13.22M | 0.00 | 0.00 |
Savara, Inc.DFND | COM | 24.47M | SH | $133.61M 7.60% | 24.47M | 0.00 | 0.00 |
Monte Rosa Therapeutics, Inc.DFND | COM | 7.69M | SH | $126.54M 7.19% | 7.69M | 0.00 | 0.00 |
MBX Biosciences, Inc.DFND | COM | 3.61M | SH | $107.89M 6.13% | 3.61M | 0.00 | 0.00 |
Zenas BioPharma, Inc.DFND | COM | 4.02M | SH | $78.65M 4.47% | 4.02M | 0.00 | 0.00 |
Coursera, Inc.DFND | COM | 12.87M | SH | $74.89M 4.26% | 12.87M | 0.00 | 0.00 |
Aurinia Pharmaceuticals, Inc.DFND | COM | 3.97M | SH | $58.83M 3.34% | 3.97M | 0.00 | 0.00 |
ORIC Pharmaceuticals, Inc.DFND | COM | 4.12M | SH | $52.18M 2.97% | 4.12M | 0.00 | 0.00 |
CRISPR Therapeutics AGDFND | NAMEN AKT | 1.06M | SH | $50.36M 2.86% | 1.06M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.DFND | COM | 1.96M | SH | $21.78M 1.24% | 1.96M | 0.00 | 0.00 |
CVRx, Inc.DFND | COM | 2.03M | SH | $19.17M 1.09% | 2.03M | 0.00 | 0.00 |
Korro Bio, Inc.DFND | COM | 1.30M | SH | $14.69M 0.84% | 1.30M | 0.00 | 0.00 |
X4 Pharmaceuticals, Inc.DFND | COM | 3.23M | SH | $13.36M 0.76% | 3.23M | 0.00 | 0.00 |
Champions Oncology, Inc.DFND | COM NEW | 1.71M | SH | $9.85M 0.56% | 1.71M | 0.00 | 0.00 |
Black Diamond Therapeutics, Inc.DFND | COM | 4.45M | SH | $9.48M 0.54% | 4.45M | 0.00 | 0.00 |
Inventiva SADFND | ADS | 1.46M | SH | $8.03M 0.46% | 1.46M | 0.00 | 0.00 |
Nkarta, Inc.DFND | COM | 3.57M | SH | $7.53M 0.43% | 3.57M | 0.00 | 0.00 |
LeonaBio, Inc.DFND | COM | 464.40K | SH | $4.77M 0.27% | 464.40K | 0.00 | 0.00 |
Senti Biosciences, Inc.DFND | COM NEW | 3.78M | SH | $3.07M 0.17% | 3.78M | 0.00 | 0.00 |
Marker Therapeutics, Inc.DFND | COM NEW | 1.63M | SH | $2.11M 0.12% | 1.63M | 0.00 | 0.00 |
OnKure Therapeutics, Inc.DFND | COM CL A | 478.55K | SH | $1.98M 0.11% | 478.55K | 0.00 | 0.00 |
Gossamer Bio, Inc.DFND | COM | 1M | SH | $328.5K 0.02% | 1M | 0.00 | 0.00 |
Page 1 of 2